Latest News and Comment from Education

Tuesday, November 19, 2019

Research, the Media, and the Market: A Cautionary Tale | radical eyes for equity

Research, the Media, and the Market: A Cautionary Tale | radical eyes for equity

Research, the Media, and the Market: A Cautionary Tale

Reporting in The New York TimesGina Kolata offers a compelling lede:
The findings of a large federal study on bypass surgeries and stents call into question the medical care provided to tens of thousands of heart disease patients with blocked coronary arteries, scientists reported at the annual meeting of the American Heart Association on Saturday.
The new study found that patients who received drug therapy alone did not experience more heart attacks or die more often than those who also received bypass surgery or stents, tiny wire cages used to open narrowed arteries.
And Julie Steenhuysen adds an interesting detail to this new major study: “At least two prior studies determined that artery-clearing and stenting or bypass surgery in addition to medical treatment does not significantly lower the risk of heart attacks or death compared with non-invasive medical approaches alone.”
But these details may prove to be the most important ones of all: “Over $8 billion worth of coronary stents will be sold annually by 2025, according to a new research report by Global Market Insights, Inc. The increase over the years will be created by an increase in artery diseases coupled with a growing demand for minimally invasive surgeries,” explains Stephen Mraz.
So now let’s do the math. If heart doctors shift to what the new research shows, “The nation could save more than $775 million a year by not giving stents to the 31,000 patients who get the devices even though they have no chest pain, Dr. Hochman said,” reports Kolata.
Better and less intrusive patient care, lower overall medical costs for a U.S. healthcare system already overburdened—what is there to keep the medical profession from embracing compelling scientific research?
Well, the market of course.
Lower costs come from fewer heart surgeries, meaning heart surgeons lose income—and possibly patients.
Keep in mind that while the medical profession decades ago emphasized best practice in prescribing antibiotics (only when bacterial infections are CONTINUE READING: Research, the Media, and the Market: A Cautionary Tale | radical eyes for equity